文献速递乳腺癌放疗

乳房切除术后放疗对即刻组织扩张器联合脱细胞真皮基质重建的影响:前瞻性临床试验结果

Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial.
PubMed 文献 · Pract Radiat Oncol · 2019-05-04

该前瞻性单臂研究纳入32例I-III期乳腺癌患者,接受乳房切除术、即刻组织扩张器联合脱细胞真皮基质重建及乳房切除术后放疗(PMRT)。中位随访24个月,26例可评估患者中2年成功率为65.4%,93.5%患者完成最终重建,多数患者(医生评估79.2%)获得良好至优秀的美容效果。

要点

  • PMRT联合即刻TE-ADM重建的2年成功率为65.4%(17/26)。
  • 93.5%(29/31)患者完成最终重建,医生评估79.2%美容效果良好至优秀。
  • 失败原因包括美容效果一般、感染、严重包膜挛缩、重大修整及未完成重建。

核心结论

  • 多数(65.4%)接受即刻TE-ADM重建后PMRT的患者达到成功标准,93.5%完成最终重建,79.2%医生评估美容效果良好至优秀。

研究设计与样本

  • 前瞻性单臂研究,2009至2012年纳入32例I-III期乳腺癌患者,接受乳房切除术、即刻TE-ADM重建及PMRT。
  • 主要目标为PMRT后2年的成功率,定义为最终重建完整、无重大并发症且医生评估美容效果优秀或良好。

主要发现

  • 中位随访24个月,31/32例(96.9%)已知最终重建状态,29/31例(93.5%)完成最终重建。
  • 26例可评估患者中2年成功率为65.4%(17/26)。
  • 失败原因包括美容效果一般(n=2)、感染(n=2)、严重包膜挛缩(n=1)、重大修整(n=2)及未完成最终重建(n=2)。
  • 基于患者感知的2年整体美容效果良好至优秀为62.5%(15例),医生评估为79.2%(19例)。

关键数值与推荐

  • 成功定义为PMRT后2年最终重建完整、无重大并发症且医生评估美容效果优秀或良好。
  • 2年成功率65.4%(17/26),最终重建完成率93.5%(29/31),医生评估良好至优秀美容效果79.2%(19/26)。

临床怎么用

  • 对于接受乳房切除术及即刻TE-ADM重建的乳腺癌患者,PMRT后多数可完成最终重建并获得良好美容效果。
  • 需关注感染、严重包膜挛缩及重大修整等并发症风险,并个体化评估放疗与重建策略。

局限性

  • 单臂研究,样本量较小(32例),中位随访仅24个月。
  • 部分患者因转移、撤回知情或出国而不可评估,可能影响结果解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Postmastectomy radiation therapy (PMRT) delivered to an immediate reconstruction increases the risk of surgical complications. Although acellular dermal matrix (ADM) has been used with immediate tissue expander (TE) reconstruction to improve cosmetic outcomes and minimize capsular contracture, there is a paucity of data on this approach in the setting of PMRT. METHODS AND MATERIALS: Thirty-two patients with stage I to III breast cancer were treated with mastectomy, immediate TE-ADM reconstruction, and PMRT between 2009 and 2012 in a prospective single-arm study. The primary objective was the "success" rate, determined by the number of patients at 2 years after PMRT having an intact final reconstruction, no major complications, and a cosmetic outcome rated by a physician as excellent or good. RESULTS: The median follow-up was 24 months. Final reconstruction status was known in 31 of 32 patients (96.9%; 1 patient left the country) and completed in 29 of 31 patients (93.5%; implant, n = 26; flap, n = 1; both, n = 2; none, n = 2). At 2 years, 6 patients were unevaluable (metastatic disease, n = 3; withdrawn consent, n = 1; left the country, n = 2). Of 26 evaluable patients, the success rate was 65.4% (17 of 26). Lack of success was the result of "fair" cosmesis (n = 2), infection (n = 2), severe capsular contracture (n = 1), major revision (n = 2), and no final reconstruction (n = 2). Most patients had good-to-excellent 2-year overall cosmesis based on patient perception (15; 62.5%) and physician evaluation (19; 79.2%). CONCLUSIONS: To the best of our knowledge, this is the first dedicated prospective trial evaluating long-term cosmetic and complication outcomes in patients treated with immediate TE-ADM reconstruction followed by PMRT. Most patients (65.4%) met the success criteria in this prospective single-arm series. The great majority (93.5%) achieved final reconstruction; most had good-to-excellent overall cosmetic outcomes (79.2%). The results with longer follow-up will be of interest, and further investigation of strategies to optimize reconstruction with PMRT are warranted.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Atkins KM, Truong LT, Rawal B, et al. Effects of Postmastectomy Radiation Therapy on Immediate Tissue Expander and Acellular Dermal Matrix Reconstruction: Results of a Prospective Clinical Trial. Pract Radiat Oncol. 2019. PMID: 31063823. doi:10.1016/j.prro.2019.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。